Publications by authors named "Sarah Moyle"

Claim this Profile
E
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Navin Venkatraman, Alfred B Tiono, Georgina Bowyer, Duncan G Bellamy, Lisa K Stockdale, Sarah Moyle

Lancet Microbe· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions.
Ekta Mukhopadhyay, Florian Brod, Philip Angell-Manning, Nicola Green, Richard D Tarrant, Sarah P Moyle

Biotechnol Bioeng· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Hans de Graaf, Ruth O Payne, Iona Taylor, Kazutoyo Miura, Carol A Long, Sarah Moyle

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Membrane Capacitance in Cardiac Impulse Conduction: An Optogenetic Study With Non-excitable Cells Coupled to Cardiomyocytes.
Stefano Andrea De Simone, Sarah Moyle, Andrea Buccarello, Christian Dellenbach, Jan Pavel Kucera

Front Physiol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop.
Glyn Stacey, Peter Andrews, Curtis Asante, Ivana Barbaric, Jaqueline Barry, Sarah Moyle

Regen Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production, quality control, stability, and potency of cGMP-produced RH5.1 protein vaccine expressed in S2 cells.
Jing Jin, Richard D Tarrant, Emma J Bolam, Philip Angell-Manning, Max Soegaard, Sarah Moyle

NPJ Vaccines· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.
Ruth O Payne, Sarah E Silk, Sean C Elias, Kathryn H Milne, Thomas A Rawlinson, Sarah Moyle

JCI Insight· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
Susanne H Hodgson, Katie J Ewer, Carly M Bliss, Nick J Edwards, Thomas Rampling, Sarah Moyle

J Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
Susanne H Hodgson, Prateek Choudhary, Sean C Elias, Kathryn H Milne, Thomas W Rampling, Sarah Moyle

Mol Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
Domtila Kimani, Ya Jankey Jagne, Momodou Cox, Eva Kimani, Carly M Bliss, Sarah Moyle

Mol Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.
Katie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, Katharine A Collins, Susanne H Sheehy, Sarah Moyle

Nat Commun· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.
Nicola Borthwick, Tina Ahmed, Beatrice Ondondo, Peter Hayes, Annie Rose, Sarah Moyle

Mol Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
Caroline Ogwang, Muhammed Afolabi, Domtila Kimani, Ya Jankey Jagne, Susanne H Sheehy, Sarah Moyle

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
Susanne H Sheehy, Christopher J A Duncan, Sean C Elias, Prateek Choudhary, Sumi Biswas, Sarah Moyle

Mol Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study.
Jeffrey I Stewart, Sarah Moyle, Gerard J Criner, Carla Wilson, Ron Tanner

COPD· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
Susanne H Sheehy, Christopher J A Duncan, Sean C Elias, Sumi Biswas, Katharine A Collins, Sarah Moyle

PLoS One· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
Geraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, Katharine A Collins, Sean C Elias, Sarah Moyle

J Infect Dis· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Susanne H Sheehy, Christopher J A Duncan, Sean C Elias, Katharine A Collins, Katie J Ewer, Sarah Moyle

Mol Ther· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons.
Wilson C J Chung, Sarah S Moyle, Pei-San Tsai

Endocrinology· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans.
Nate W Kahn, Shane L Rea, Sarah Moyle, Alison Kell, Thomas E Johnson

Biochem J· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis